Biogen Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Biogen Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Biogen Inc. stocks after a simple registration process. </div>

Q: How to buy Biogen Inc. shares in India?

<div> To buy Biogen Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Biogen Inc. and you are done!</div> </div>

Q: What is the share price of Biogen Inc.?

<div>The share price of Biogen Inc. is USD 148.7 as on 30 Jan.</div>

Q: What is the Market Capitalization of Biogen Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Biogen Inc. is USD 21.67B as on 30 Jan.</div>

Q: What is the PE ratio of Biogen Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Biogen Inc. is 13.15 as on 30 Jan. </div>

Q: Is Biogen Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Biogen Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Biogen Inc. operate?

<div> Biogen Inc. operates in Healthcare / Drug manufacturers - general

Healthcare Drug manufacturers - general

$148.7

+4.32

(30 Jan)

Loading Chart

Previous close

$148.70

Open

$148.70

Today’s high

$147.64

Today’s low

$145.31

52W low

$139.71

52W high

$246.44

-39.73%

-11.72%

13.15

EPS (TTM)

11.06

Shares O/S

145.72M

Market cap

21.67B

Insights

BIIB price is below its 200 day moving average

In beta. Send feedback here.

Compare with other stock

About Biogen Inc.

Biogen Inc. is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases.

The Company’s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS; and FUMADERM for the treatment of severe plaque psoriasis. It also has collaborations for the commercialization of LEQEMBI, ZURZUVAE, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS, LUNSUMIO, and COLUMVI. It commercializes a portfolio of biosimilars of advanced biologics including BENEPALI, IMRALDI, FLIXABI, and BYOOVIZ. .

FAQs

Can I buy Biogen Inc. shares in India?

How to buy Biogen Inc. shares in India?

What is the share price of Biogen Inc.?

What is the Market Capitalization of Biogen Inc.?

What is the PE ratio of Biogen Inc.?

Is Biogen Inc. a good stock to buy?

In which sector / industry does Biogen Inc. operate?